4
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Instrumentos de avaliação da neuropatia periférica induzida por quimioterapia no paciente com mieloma múltiplo Translated title: Evaluation instruments of peripheral neuropathy induced by chemotherapy in patients with multiple myeloma

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Resumo Objetivo: Identificar instrumentos de avaliação da neuropatia periférica induzida por quimioterapia que possam ser traduzidos ou adaptados para monitoramento dessa reação adversa a medicamentos em pacientes com mieloma múltiplo. Método: Revisão narrativa, realizada entre julho de 2018 a maio de 2019. Foram elegíveis artigos publicados em inglês e português, entre junho de 2007 a janeiro de 2019, disponíveis na íntegra de maneira livre ou em periódicos do Portal da CAPES Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. Foram excluídos estudos com animais, monografias, guidelines, teses, casos clínicos e estudos que não da área de saúde. Resultados: Foram identificados cinco instrumentos: Patient Neurotoxicity Questionnaire; Funcional Assessment of Cancer Therapy/ Gynecologyc Group – Neurotoxicity; Chemotherapy-Induced Peripheral Neuropathy Assessment Tool; Funcional Assessment Cancer Therapy/Taxane; Indication for Common Toxicity Criteria – Grading of Peripheral Neuropathy Questionnaire (ICPNQ). Após análise de cada ferramenta apresentada, o ICPNQ se mostrou válido e aplicável na prática clínica, porém, encontra-se em língua inglesa. Conclusão: A tradução e validação do instrumento ICPNQpara o português, possibilitaria sua incorporação à práticaclínica no monitoramento da neuropatia periférica induzidapor quimioterapia em pacientes com Mieloma Múltiplo.

          Translated abstract

          Abstract Objective: To identify instruments for evaluation of peripheral neuropathy induced by chemotherapy that can be translated or adapted to monitor this adverse drug reaction in patients with multiple myeloma. Method: Narrative review, conducted between July 2018 and may 2019. Articles published in English and Portuguese were eligible between June2007 and January 2019, available in full in a free manner or in periodicals of the CAPES Coordination Portal for Improvement of Level Personnel Higher. Animal studies, monographs, guidelines, theses, clinical cases and non-health studies were excluded. Results: Five instruments were identified:Patient Neurotoxicity Questionnaire;Funcional Assessment of Cancer Therapy/Gynecologyc Group – Neurotoxicity;Chemotherapy-Induced Peripheral NeuropathyAssessment Tool; Funcional AssessmentCancer Therapy/Taxane; Indicationfor Common Toxicity Criteria – Grading ofPeripheral Neuropathy Questionnaire (ICPNQ). After analyzing each tool presented,the ICPNQ proved to be valid andapplicable in clinical practice, however, itis in the English language. Conclusion: The translation and validation of the ICPNQ instrument into Portuguese would allow its incorporation into clinical practice in the monitoring of peripheral neuropathy induced by chemotherapy in patients with multiple myeloma.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

          Estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. We review the sources and methods used in compiling the national cancer incidence and mortality estimates, and briefly describe the key results by cancer site and in 20 large "areas" of the world. Overall, there were 14.1 million new cases and 8.2 million deaths in 2012. The most commonly diagnosed cancers were lung (1.82 million), breast (1.67 million), and colorectal (1.36 million); the most common causes of cancer death were lung cancer (1.6 million deaths), liver cancer (745,000 deaths), and stomach cancer (723,000 deaths). © 2014 UICC.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Multiple myeloma

            Multiple myeloma is a malignancy of terminally differentiated plasma cells, and patients typically present with bone marrow infiltration of clonal plasma cells and monoclonal protein in the serum and/or urine. The diagnosis of multiple myeloma is made when clear end-organ damage attributable to the plasma cell proliferative disorder or when findings that suggest a high likelihood of their development are present. Distinguishing symptomatic multiple myeloma that requires treatment from the precursor stages of monoclonal gammopathy of undetermined significance and smouldering multiple myeloma is important, as observation is the standard for those conditions. Much progress has been made over the past decade in the understanding of disease biology and individualized treatment approaches. Several new classes of drugs, such as proteasome inhibitors and immunomodulatory drugs, have joined the traditional armamentarium (corticosteroids, alkylating agents and anthracyclines) and, along with high-dose therapy and autologous haemopoietic stem cell transplantation, have led to deeper and durable clinical responses. Indeed, an increasing proportion of patients are achieving lasting remissions, raising the possibility of cure for this disease. Success will probably depend on using combinations of effective agents and treating patients in the early stages of disease, such as patients with smouldering multiple myeloma.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Revisão sistemática X revisão narrativa

                Bookmark

                Author and article information

                Journal
                ofil
                Revista de la OFIL
                Rev. OFIL·ILAPHAR
                Organización de Farmacéuticos Ibero-Latinoamericanos (Madrid, Madrid, Spain )
                1131-9429
                1699-714X
                December 2022
                : 32
                : 4
                : 387-393
                Affiliations
                [3] Goiás orgnameUniversidade Federal de Goiás orgdiv1Hospital das Clínicas Brazil
                [1] Goiás orgnameUniversidade Federal de Goiás orgdiv1Hospital das Clínicas Brazil
                [2] Goiás orgnameUniversidade Federal de Goiás orgdiv1Hospital das Clínicas Brazil
                [4] Goiás orgnameUniversidade Federal de Goiás orgdiv1Faculdade de Farmácia Brazil
                Article
                S1699-714X2022000400012 S1699-714X(22)03200400012
                10.4321/s1699-714x20220004000012
                eb43cde5-f06b-426c-ab32-861c41a961ab

                This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 17 February 2021
                : 22 March 2021
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 23, Pages: 7
                Product

                SciELO Spain


                Efeitos colaterais e reações adversas relacionados a medicamentos,tratamento farmacológico,doenças do sistema nervoso periférico,doenças hematológicas,Drug-related side effects and adverse reactions,antineoplastic agents,drug therapy,peripheral nervous system diseases,hematologic diseases,antineoplásicos

                Comments

                Comment on this article